ICMR-National Institute of Epidemiology, Chennai, India.
Health Technology Assessment Resource Centre ICMR-NIE, ICMR-National Institute of Epidemiology, Ayapakkam, Chennai, 600077, India.
Qual Life Res. 2024 Jul;33(7):1781-1793. doi: 10.1007/s11136-024-03646-8. Epub 2024 Apr 6.
Evaluating the Health-related quality of life (HRQoL) of individuals with Parkinson's disease (PD) holds significant importance in clinical and research settings. The EQ-5D is a widely recognized tool for comprehensive measurement of HRQoL using utility values. This study aims to systematically review and synthesize EQ-5D utility values from existing literature on patients with PD and their caregivers.
We conducted a systematic search for studies that provided EQ-5D utility scores for patients with PD, using PubMed-Medline, Scopus, and Embase and selected the studies. The selected studies underwent systematic review, including an assessment of their quality. We performed a meta-analysis using a random-effect model and conducted a meta-regression analysis to investigate sources of heterogeneity among the studies.
The search result of 13,417 articles that were reviewed, 130 studies with 33,914 participants were selected for systematic review, and 79 studies were included for meta-analysis. The pooled EQ-5D utility values and visual analog score (VAS) among PD were 62.72% (60.53-64.93, I = 99.56%) and 0.60 (0.55-0.65, I = 99.81%), respectively. The pooled scores for caregivers' EQ-VAS and EQ-5D utility were 70.10% (63.99-76.20, I = 98.25%) and 0.71 (0.61-0.81, I = 94.88%), respectively. Disease duration (P < 0.05) showed a negative correlation with EQ-5D utility values on meta-regression.
The pooled utility values of PD and their caregivers help to understand their HRQoL and aid in conducting health economics research. The negative association between disease duration and utility values highlights the evolving nature of HRQoL challenges, suggesting the need for appropriate long-term disease management.
评估帕金森病(PD)患者的健康相关生活质量(HRQoL)在临床和研究领域具有重要意义。EQ-5D 是一种广泛认可的工具,可通过效用值全面衡量 HRQoL。本研究旨在系统地综述和综合现有 PD 患者及其照护者的 EQ-5D 效用值文献。
我们系统地检索了提供 PD 患者 EQ-5D 效用评分的研究,使用了 PubMed-Medline、Scopus 和 Embase,并对这些研究进行了选择。对选定的研究进行了系统评价,包括对其质量的评估。我们使用随机效应模型进行了荟萃分析,并进行了荟萃回归分析,以调查研究之间异质性的来源。
共检索到 13417 篇文章,经过综述,有 130 项研究纳入了 33914 名参与者,其中 79 项研究进行了荟萃分析。PD 的 EQ-5D 效用值和视觉模拟评分(VAS)的合并值分别为 62.72%(60.53-64.93,I=99.56%)和 0.60(0.55-0.65,I=99.81%)。照护者的 EQ-VAS 和 EQ-5D 效用的合并评分分别为 70.10%(63.99-76.20,I=98.25%)和 0.71(0.61-0.81,I=94.88%)。疾病持续时间(P<0.05)在荟萃回归中与 EQ-5D 效用值呈负相关。
PD 及其照护者的汇总效用值有助于了解他们的 HRQoL,并有助于进行健康经济学研究。疾病持续时间与效用值之间的负相关关系突出了 HRQoL 挑战的演变性质,表明需要进行适当的长期疾病管理。